Patents by Inventor Yasuo Irie

Yasuo Irie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6797256
    Abstract: The present invention provide a method for assessing the sensitivity to a pyrimidine drug such as 5-FU which is degraded in the pyrimidine metabolic pathway, specifically in vivo pyrimidine metabolizing activity, of an individual subject; and a preparation useful for the assessment. The present invention can be carried out by: administering a preparation comprising as an active ingredient a pyrimidine compound or its metabolite which acts as a substrate for a pyrimidine metabolizing enzyme, in which compound or metabolite at least one of C, O and N is labeled with an isotope; and assessing in vivo pyrimidine metabolizing activity based on the amount of excreted metabolite.
    Type: Grant
    Filed: August 14, 2001
    Date of Patent: September 28, 2004
    Assignee: Otsuka Pharmaceutical Co. Ltd.
    Inventors: Makoto Inada, Nobuhiro Ikei, Hideji Nonomura, Yasuo Irie
  • Publication number: 20030171687
    Abstract: The present invention relates to an assay for evaluating alveolar exchange of oxygen. A 13C-labeled substrate, such as 13C-sodium bicarbonate is administered to a subject by oral or iv intake, and exhaled 13CO2 is measured. The 13CO2 in expired breath can be collected at various time points following administration of the substrate and measured in &Dgr; per mil with a mass analyzer or photometer, such as an IR spectrometer. This process can be used as a diagnostic test for the indication of, treatment and/or evaluation of the severity of respiratory tract diseases or infections.
    Type: Application
    Filed: February 26, 2003
    Publication date: September 11, 2003
    Inventors: Yasuo Irie, Anil S. Modak
  • Publication number: 20030068272
    Abstract: The present invention provide a method for measuring and assessing the capacity in an individual subject to metabolize a variety of fluorouracil drugs, such as 5-fluorouracil, which are degraded in the pyrimidine metabolic pathway, and a preparation useful for the measurement and assessment. The present invention can be carried out by: administering a preparation for determining pyrimidine metabolic capacity comprising as an active ingredient a pyrimidine compound or pyrimidine metabolic compound that acts as a substrate for a pyrimidine metabolizing enzyme, in which at least one of the carbon, oxygen, and nitrogen atoms is labeled with an isotope; and assessing in vivo pyrimidine metabolic capacity based on the behavior of an excreted metabolite.
    Type: Application
    Filed: August 1, 2002
    Publication date: April 10, 2003
    Applicant: Otsuka Pharmaceutical Co., LTD.
    Inventors: Makoto Inada, Nobuhiro Ikei, Hideji Nonomura, Yasuo Irie
  • Publication number: 20020193062
    Abstract: A device guiding disc to direct discs to a desired location includes a guiding passageway for guiding and aligning the individual discs at an exit position. A pushing device can contact the discs at the exit position and move the disc out of the guiding passageway. A roller member can be positioned adjacent the bottom of the exit position to support and translate the disc as it is pushed by the pushing device. A support device, such as a tapered roller member, can be positioned above the exit position to receive an upper edge of the disc and to operatively position the disc for subsequent contact with the pushing device wherein the disc is positioned at an inclined angle to a longitudinal axis of the guiding passageway.
    Type: Application
    Filed: June 11, 2002
    Publication date: December 19, 2002
    Inventors: Hiroshi Abe, Yasuo Irie
  • Publication number: 20020132283
    Abstract: The present invention provide a method for assessing the sensitivity to a pyrimidine drug such as 5-FU which is degraded in the pyrimidine metabolic pathway, specifically in vivo pyrimidine metabolizing activity, of an individual subject; and a preparation useful for the assessment. The present invention can be carried out by: administering a preparation comprising as an active ingredient a pyrimidine compound or its metabolite which acts as a substrate for a pyrimidine metabolizing enzyme, in which compound or metabolite at least one of C, O and N is labeled with an isotope; and assessing in vivo pyrimidine metabolizing activity based on the amount of excreted metabolite.
    Type: Application
    Filed: August 14, 2001
    Publication date: September 19, 2002
    Inventors: Makoto Inada, Nobuhiro Ikei, Hideji Nonomura, Yasuo Irie
  • Patent number: 6306647
    Abstract: A process for converting uridines to 2′,3′-dideoxy-2′,3′-didehydrouridines by reacting acetic anhydride with a 2′,3′-0-alkoxymethylideneuridine intermediate.
    Type: Grant
    Filed: December 3, 1993
    Date of Patent: October 23, 2001
    Assignee: Ajinomoto Co., Inc.
    Inventors: Hiroshi Shiragami, Yasuo Irie, Naohiko Yasuda
  • Patent number: 5488150
    Abstract: Stable crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine may be produced by treating this compound with a solvent at a temperature of at least 10.degree. C. and forming crystals in the solvent at a temperature of at least 10.degree. C. For example, crystals may be formed by crystallization out of solution, or may be formed from solid particles of the compound suspended in a solvent. Crystals formed in this way have different melting point, infra red spectrum and X-ray diffraction patterns from previously known forms of the compound and have enhanced processability, eg. stability to grinding.
    Type: Grant
    Filed: December 14, 1993
    Date of Patent: January 30, 1996
    Assignee: Ajinomoto Co., Inc.
    Inventors: Michito Sumikawa, Yoshihito Koguchi, Takao Ohgane, Yasuo Irie, Satoji Takahashi
  • Patent number: 5463116
    Abstract: Stable crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine may be produced by treating this compound with a solvent at a temperature of at least 10.degree. C. and forming crystals in the solvent at a temperature of at least 10.degree. C. For example, crystals may be formed by crystallization out of solution, or may be formed from solid particles of the compound suspended in a solvent. Crystals formed in this way have different melting point, infra red spectrum and X-ray diffraction patterns from previously known forms of the compound and have enhanced processability, e.g., stability to grinding.
    Type: Grant
    Filed: February 2, 1994
    Date of Patent: October 31, 1995
    Assignee: Ajinomoto Co., Inc.
    Inventors: Michito Sumikawa, Yoshihito Koguchi, Takao Ohgane, Yasuo Irie, Satoji Takahashi
  • Patent number: 4970148
    Abstract: A method of producing dideoxyinosine involving contacting as a substrate 2',3'-dideoxyadenosine with a microorganism which is capable of converting the substrate into 2',3'-dideoxyinosine.
    Type: Grant
    Filed: October 7, 1988
    Date of Patent: November 13, 1990
    Assignee: Ajinomoto Co., Inc.
    Inventors: Kenzo Yokozeki, Hideyuki Shirae, Katsunori Kobayashi, Hiroshi Shiragami, Yasuo Irie
  • Patent number: 4962193
    Abstract: A biological process for producing a 2',3'-dideoxynucleoside from 2',3'-dideoxyuridine is disclosed. the 2',3'-dideoxynucleoside can be purified readily using a porous nonpolar resin adsorbent.
    Type: Grant
    Filed: December 28, 1988
    Date of Patent: October 9, 1990
    Assignee: Ajinomoto Co., Inc.
    Inventors: Kenzo Yokozeki, Hideyuki Shirae, Hiroshi Shiragami, Yasuo Irie, Naohiko Yasuda, Masaru Otani, Toshiya Tanabe
  • Patent number: 4835104
    Abstract: A biological process for producing a 2',3'-dideoxyncleoside from 2',3'-dideoxyuridine is disclosed. The 2',3'-dideoxynucleoside can be purified readily using a porous nonpolar resin adsorbent.
    Type: Grant
    Filed: May 9, 1988
    Date of Patent: May 30, 1989
    Assignee: Ajinomoto Co., Inc., Patent & Licensing Department
    Inventors: Kenzo Yokozeki, Hideyuki Shirae, Hiroshi Shiragami, Yasuo Irie, Naohiko Yasuda, Masaru Otani, Toshiya Tanabe
  • Patent number: 4786737
    Abstract: A compound which is: ##STR1## wherein R may be 1 to 5 H, Cl, Br, F, C.sub.1 -C.sub.4 straight chain or branched alkyl, OH, or CF.sub.3.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: November 22, 1988
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yasuo Irie, Fusayoshi Kakizaki, Chieko Ishijima, Michito Sumikawa, Naohiko Yasuda
  • Patent number: 4720554
    Abstract: A compound which is: ##STR1## wherein R may be 1 to 5 H, Cl, Br, F, C.sub.1 -C.sub.4 straight chain or branched alkyl, OH, or CF.sub.3.
    Type: Grant
    Filed: November 25, 1986
    Date of Patent: January 19, 1988
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yasuo Irie, Fusayoshi Kakizaki, Chieko Ishijima, Michito Sumikawa, Naohiko Yasuda
  • Patent number: 4514146
    Abstract: In a propeller for use in a ship of the type comprising 4 or more even number blades, at least one of two adjacent blades is inclined forwardly or rearwardly or one inclined forwardly and the other rearwardly so as to make different the rake angles of the two blades. The pitch angle of the rearwardly inclined blade is made larger than that of the forwardly inclined blade. With this construction the mutual interference between adjacent blades is efficiently utilized to prevent decrease in the efficiency even when operating conditions and the diameter of the propeller vary.
    Type: Grant
    Filed: October 22, 1982
    Date of Patent: April 30, 1985
    Assignee: Mitsui Engineering & Shipbuilding Co., Ltd.
    Inventors: Takeo Nojiri, Yasuo Irie
  • Patent number: 4423215
    Abstract: A method of preparing sodium salts of an imidazoledicarboxylic acid derivative of a substituted cephalosporin represented by the general formula of ##STR1## where X is a radical selected from the group consisting of hydrogen, halogen, hydroxyl, alkyl, aryl, aralkyl, alkoxy, aryloxy, aralkyloxy, mercapto, alkylthio, arylthio, aralkylthio, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl, alkylsulfinyl, arylsulfinyl, aralkylsulfinyl, amino, mono- or dialkylamino, mono- or diarylamino, mono- or diaralkylamino, acylamino, sulfonic acid, nitro or heterocyclic group;and where R is a radical selected from hydrogen, an organic radical such as alkyl, aryl or aralkyl or a heterocyclic group, said organic radical and heterocyclic group being optionally substituted;said method comprising reacting a compound represented by the following formula: ##STR2## with 4-pyridineethanesulfonic acid in an aqueous solution of sodium iodide and subsequently recovering the salt.
    Type: Grant
    Filed: March 2, 1982
    Date of Patent: December 27, 1983
    Assignee: Ajinomoto Company, Inc.
    Inventors: Naohiko Yasuda, Hisao Iwagami, Yasuo Irie, Eiji Nakanishi, Hideomi Saito
  • Patent number: D441797
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: May 8, 2001
    Assignee: Asahi Seiko Kabushiki Kaisha
    Inventor: Yasuo Irie
  • Patent number: D432286
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: October 17, 2000
    Assignee: Asahi Seiko Co., Ltd.
    Inventor: Yasuo Irie